Pfizer Scraps Trial, Investors Worry Medarex Next
Melanoma treatment's value questioned after similar drug performs poorly in trial. 7 months ago
Forbes Click here to Read the Full StoryMelanoma treatment's value questioned after similar drug performs poorly in trial. 7 months ago
Forbes Click here to Read the Full Story
Digg
del.icio.us
Reddit
Stumble
Newsvine
Facebook